John B. Ketchum - 29 Aug 2023 Form 4 Insider Report for Tango Therapeutics, Inc. (TNGX)

Role
Director
Signature
/s/ Douglas Barry, as attorney-in-fact
Issuer symbol
TNGX
Transactions as of
29 Aug 2023
Net transactions value
$0
Form type
4
Filing time
31 Aug 2023, 16:07:47 UTC
Next filing
07 Jun 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TNGX Common Stock Award $0 +10,000 $0.000000 10,000 29 Aug 2023 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TNGX Stock Option (Right to Buy) Award $0 +60,000 $0.000000 60,000 29 Aug 2023 Common Stock 60,000 $7.19 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These shares are represented by restricted stock units (the "RSUs"). Each RSU represents a contingent right to receive one share of Common Stock of the Issuer. The RSUs will vest in three substantially equal annual installments on each of August 19, 2024, August 18, 2025 and August 17, 2026, subject to the Reporting Person's continuous service with the Issuer as of each such vesting date.
F2 This option shall vest and become exercisable in 36 substantially equal monthly installments over a period of three years beginning on August 29, 2023, subject to the Reporting Person's continuous service with the Issuer as of each such vesting date.